Shanxi C&Y Pharmaceutical Group Co Ltd Financial Flexibility Index
Shanxi C&Y Pharmaceutical Group Co Ltd financial flexibility index. Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥63.30 Million (operating CF CN¥52.93 Million minus capex CN¥10.37 Million) represents 0% of total liabilities (CN¥972.67 Million). See 300254 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)
Financial flexibility index of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Shanxi C&Y Pharmaceutical Group Co Ltd across 18 annual periods. Check Shanxi C&Y Pharmaceutical Group Co Ltd (300254) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shanxi C&Y Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2008–2025)
Shanxi C&Y Pharmaceutical Group Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Shanxi C&Y Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 300254 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | CN¥131.08 Million | CN¥96.77 Million | CN¥1.05 Billion | ▼ -3.0% |
| 2024 | 0.13x | CN¥122.44 Million | CN¥70.94 Million | CN¥949.55 Million | ▲ +17.7% |
| 2023 | 0.11x | CN¥71.73 Million | CN¥37.81 Million | CN¥654.64 Million | ▼ -7.9% |
| 2022 | 0.12x | CN¥101.66 Million | CN¥74.88 Million | CN¥854.64 Million | ▼ -30.5% |
| 2021 | 0.17x | CN¥133.85 Million | CN¥96.92 Million | CN¥782.23 Million | ▲ +1400.2% |
| 2020 | 0.01x | CN¥10.58 Million | CN¥-20.88 Million | CN¥927.91 Million | ▼ -88.8% |
| 2019 | 0.10x | CN¥88.17 Million | CN¥69.63 Million | CN¥869.43 Million | ▼ -15.9% |
| 2018 | 0.12x | CN¥68.03 Million | CN¥38.44 Million | CN¥564.47 Million | ▼ -53.3% |
| 2017 | 0.26x | CN¥141.17 Million | CN¥40.10 Million | CN¥547.42 Million | ▲ +33.3% |
| 2016 | 0.19x | CN¥92.43 Million | CN¥41.65 Million | CN¥477.74 Million | ▲ +65.0% |
| 2015 | 0.12x | CN¥51.13 Million | CN¥15.44 Million | CN¥435.93 Million | ▼ -63.9% |
| 2014 | 0.32x | CN¥116.39 Million | CN¥82.19 Million | CN¥358.17 Million | ▼ -24.2% |
| 2013 | 0.43x | CN¥138.49 Million | CN¥80.58 Million | CN¥323.21 Million | ▼ -6.2% |
| 2012 | 0.46x | CN¥80.43 Million | CN¥35.05 Million | CN¥175.99 Million | ▼ -21.6% |
| 2011 | 0.58x | CN¥70.78 Million | CN¥4.75 Million | CN¥121.39 Million | ▼ -23.3% |
| 2010 | 0.76x | CN¥99.81 Million | CN¥52.03 Million | CN¥131.25 Million | ▼ -8.5% |
| 2009 | 0.83x | CN¥117.88 Million | CN¥105.55 Million | CN¥141.91 Million | ▲ +354.9% |
| 2008 | -0.33x | CN¥-38.28 Million | CN¥-39.16 Million | CN¥117.45 Million | — |